The combination of avutometinib and defactinib is the first FDA-approved treatment for KRAS-mutated recurrent LGSOC. Approval was based on the phase 2 RAMP-201 trial, showing a 44% overall ...

Iterum Therapeutics PLC (ITRM) reports reduced operating expenses and extends cash runway, while gearing up for ORLYNVAH's potential market launch. --Preparing for Potential Launch of ORLYNVAHTM ...

Zevaskyn is the first FDA-approved treatment for RDEB wounds with a single application. The FDA has approved Zevaskyn for the treatment of recessive dystrophic epidermolysis bullosa, the company ...

Merck, known as MSD outside the United States and Canada announced that the Food and Drug Administration (FDA) has approved two new ... two new antiretroviral treatment options, Delstrigo and ...

Please provide your email address to receive an email when new articles are posted on . Atzumi is the first dihydroergotamine-based nasal powder approved for migraine treatment in adults.

The US Food and Drug Administration (FDA) has approved Swiss drugmaker Ferring Pharmaceuticals’ Adstiladrin (nadofaragene firedenovec-vncg) for the treatment of adult patients with high-risk ...

The latest canine otitis externa medication is the only FDA-approved, 1-dose, in-clinic treatment for Pseudomonas aeruginosa and other pathogens. MSD Animal Health, a division of Merck & Co, Inc, ...

New York, April 30, 2025 (GLOBE NEWSWIRE) -- Muscular Dystrophy Association (MDA) applauds the U.S. Food and Drug Administration (FDA) approval of IMAAVY TM (nipocalimab-aahu) for the treatment of ...

Common side effects include elevated lab markers, nausea, fatigue, rash, and various other symptoms affecting multiple body systems. Treatment with the Avmapki Fakzynja Co-pack received accelerated ...

This marks the first and only FDA-approved medicine for low-grade serous ovarian cancer (LGSOC) that tests positive for a gene change known as the KRAS mutation. The treatment includes two drugs ...